abstract |
The purpose of the present invention is to provide a novel therapeutic agent for dyslipidemia, which targets angiopoietin-like factor 3. According to the present invention, a vaccine composition is provided, which contains a peptide having a portion of the sequence for angiopoietin-like factor 3 (ANGPTL3) as an active ingredient, in which the peptide comprises at least one peptide selected from the group consisting of EPKSRFA (SEQ ID NO: 3), EPKSRFAMLD (SEQ ID NO: 4) and EPKSRFAMLDDVK (SEQ ID NO: 5). |